secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRISTOL MYERS SQUIBB CO (BMY)
CIK:        0000014272
Form:       8-K
Filed at:   2022-06-15T23:59:59+00:00
Accession:  0001140361-22-023069
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bristol-Myers Squibb elects Dr. Deepak L. Bhatt to Board of Directors
---------------------------------------------------------------------

- Dr. Deepak L. Bhatt elected to Board effective June 14, 2022; Board size increases to 11.
- Dr. Bhatt will serve on the Science & Technology Committee.
- He brings over 20 years of cardiovascular research experience; currently Executive Director at Brigham and Women's Hospital.
- Compensation per standard non-employee director program: $105,000 annual retainer plus $200,000 DSU award.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/14272/000114036122023069/0001140361-22-023069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/14272/000114036122023069/brhc10038705_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-22-023069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer